Sirolimus-Eluting Coronary Stent - Vietnam Registration 2301208ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Sirolimus-Eluting Coronary Stent in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2301208ĐKLH/BYT-HTTB and manufactured by Theo theo phụ lục.
This page provides complete technical specifications, regulatory compliance details, 3 companies making similar products including Theo theo phụ lục, Theo phụ lục, and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2301208ĐKLH/BYT-HTTB
000.00.04.G18-230317-0012
Theo theo phụ lục
Theo phụ lục
Technical Details
It is indicated for the treatment of patients with symptomatic coronary artery disease due to new or re-occluded coronary artery stenosis. The stent system is also indicated for the treatment of acute or suspected acute total coronary occlusion in patients who have failed to respond to balloon angioplasty therapy
Dates and Status
Oct 11, 2023
Sirolimus-Eluting Coronary Stent Frame
Theo phụ lục
2403645ĐKLH/BYT-HTTB
Sirolimus-Eluting Coronary Stent Frame
Theo phụ lục
2402764ĐKLH/BYT-HTTB
Sirolimus-Eluting Coronary Stent
Kamal Encon Industries Limited
2402032ĐKLH/BYT-HTTB
Sirolimus-Eluting Coronary Stent Frame
Theo theo phụ lục
2301854ĐKLH/BYT-HTTB
Sirolimus-Eluting Coronary Stent Frame
Theo theo phụ lục
2301557ĐKLH/BYT-HTTB